Spotlight-listed biotech company Cereno Scientific recently released its year-end report for 2021. CEO Sten R Sörensen visited BioStock’s studio to talk about activities in the past year, what is going on right now and which milestones the company expects to reach during 2022.
Watch the interview in Swedish with Cereno Scientific’s CEO Sten R Sörensen in the link below.
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.
We cover early-stage, growth-stage and late-stage investments. From business angels and seed investors driving medical breakthroughs, to investments empowering promising...
The Nordic region’s leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
Lås upp vårt premium-innehåll: Bli prenumerant!
Skapa konto
